Dr. Christopher S. Saigal, MD

Dr. Saigal practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Dr. Saigal's NPI, 1841219656, was assigned on July 19, 2006. Dr. Saigal graduated from David Geffen School of Medicine at UCLA in 1994. Dr. Saigal holds California license A60258.

Dr. Saigal's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Dr. Saigal's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Dr. Saigal is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Urology. Dmand AI also links Dr. Saigal to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Saigal practices, 3 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Saigal's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Saigal is board certified in urology by the American Board of Urology. Dr. Saigal is licensed in California.

Dmand AI lists enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, prostate surgery and urinary endoscopy among the conditions Dr. Saigal treats.

CMS data shows 785 Medicare services from Dr. Saigal across 15 procedure codes in 2024, for 272 Medicare patients. Medicare paid $74,088 for them.

CMS counts 272 Medicare patients who saw Dr. Saigal in 2024. The largest group is 65 to 74, with 141 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 15% are also on Medicaid. Their average risk score is 1.35, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Saigal's median patient age at 66, with 4% women.

In 2024, Dr. Saigal wrote 438 Medicare Part D claims for 139 patients. 87% of them were for generic drugs. CMS names the drug for 375 of them, across 7 drugs with 11 or more claims each, at $44,656 in total drug cost. In 2023, CMS named 301 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Saigal for performance year 2024, reported as part of a group. Dr. Saigal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Saigal as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 45 papers to Dr. Saigal, published from 2010 to 2025. 2016 was the busiest year, with 6. Dr. Saigal's most frequent co-authors are Karim Chamie, MD, Nicholas Murray Donin, MD and Mark S. Litwin, MD.

CMS Open Payments shows 73 general payments to Dr. Saigal from 11 drug and device companies from 2017 to 2025. Travel and lodging make up the largest share, 44% of the total. Astellas Pharma Global Development paid the most, $4,148.

Dmand AI lists 9 awards for Dr. Saigal, most recently Gallagher Fellow in 2009. Dr. Saigal serves on Surgical Quality Alliance and AUA Quality Improvement and Patient Safety Committee.

Dr. Saigal graduated from David Geffen School of Medicine at UCLA in 1994. Dr. Saigal is a member of ACS and AUA.

Dr. Saigal is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.